Beth Jantzen Insider Trading $APDN APPLIED DNA SCIENCES INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Beth Jantzen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Beth Jantzen. Beth Jantzen is Chief Financial Officer in APPLIED DNA SCIENCES INC ($APDN).
Beth Jantzen in APPLIED DNA SCIENCES INC
Trading Symbol: APDNIndustry: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
Position of Beth Jantzen: Chief Financial Officer
Holdings: 2,841 shares
Current Value: $4,688
Latest Transaction: Oct 21 2020
$APDN Market Capitalization: $43.48M
$APDN Previous Close: $1.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Beth Jantzen in APPLIED DNA SCIENCES INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 21 2020 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 7.54 | 13,035 | 98,284 | 13,035 | |
Jun 04 2020 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 8.36 | 6,965 | 58,227 | 6,965 | |
Dec 12 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 8.16 | 4,167 | 34,003 | 4,167 | |
Dec 12 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | D | 8.16 | 4,167 | 34,003 | 0 | |
Dec 03 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 6.96 | 4,167 | 29,002 | 4,167 | |
Dec 03 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | D | 6.96 | 4,167 | 29,002 | 0 | |
Oct 17 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 5.13 | 4,167 | 21,377 | 4,167 | |
Oct 17 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | D | 5.13 | 4,167 | 21,377 | 0 | |
Aug 31 2018 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 1.19 | 100,000 | 119,000 | 100,000 | |
Jun 29 2017 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Grant | A | 1.76 | 2,841 | 5,000 | 2,841 | 0 to 2.8 K |
Dec 22 2016 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 2.05 | 60,000 | 123,000 | 60,000 | |
Mar 15 2016 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 3.45 | 30,000 | 103,500 | 30,000 | |
Dec 23 2015 | APDN | APPLIED DNA SCIENC ... | Jantzen Beth | Chief Financial Off ... | Option Exercise | A | 2.99 | 50,000 | 149,500 | 50,000 |
Page: 1